Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None20222021202020192018201720162015201420132012201120102009200820072006 Date Title 2/9/06 Successful Muscular Dystrophy Treatment Results Using AVI BioPharma Technology Published in Nature Medicine 1/27/06 AVI BioPharma Announces Hepatitis C Virus License Agreement with Chiron 1/20/06 AVI BioPharma Reports Confirmation of Efficacy against Influenza Strains 1/13/06 AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus 1/10/06 AVI BioPharma Reports Favorable Safety and Pharmacokinetic Data From Its Clinical Trial Targeting Hepatitis C Virus 1/4/06 Increased Defense-Related Funding of AVI BioPharma Approved Pagination First page « first Previous page ‹ previous … Page 65 Page 66 Page 67 Page 68 Page 69 Page 70 Page 71 Page 72 Current page 73 Displaying 721 - 726 of 726 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None20222021202020192018201720162015201420132012201120102009200820072006 Date Title 2/9/06 Successful Muscular Dystrophy Treatment Results Using AVI BioPharma Technology Published in Nature Medicine 1/27/06 AVI BioPharma Announces Hepatitis C Virus License Agreement with Chiron 1/20/06 AVI BioPharma Reports Confirmation of Efficacy against Influenza Strains 1/13/06 AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus 1/10/06 AVI BioPharma Reports Favorable Safety and Pharmacokinetic Data From Its Clinical Trial Targeting Hepatitis C Virus 1/4/06 Increased Defense-Related Funding of AVI BioPharma Approved Pagination First page « first Previous page ‹ previous … Page 65 Page 66 Page 67 Page 68 Page 69 Page 70 Page 71 Page 72 Current page 73 Displaying 721 - 726 of 726
